Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue engineering therapy for cardiovascular disease.

Helen M Nugent1, Elazer R Edelman

  • 1Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Building 16, Room 325, Cambridge, Mass 02139, USA. ellenugent@attbi.com

Circulation Research
|May 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiorenal Hemodynamic Coupling: Mechanical Circulatory Support Augments Renal Blood Flow via Renal Vasodilation.

JACC. Basic to translational science·2026
Same author

Flow-mediated endothelial remodeling and inflammation drive developmental vascular susceptibility in ldlr loss of function.

Nature communications·2026
Same author

Toward Smart and Adaptive Endovascular Devices: The Role of Digital Twins in Precision Vascular Medicine.

Interventional cardiology clinics·2026
Same author

Endovascular Drug Delivery from Stents and Balloons in Peripheral Arteries: What Every Interventionalist Must Know.

Interventional cardiology clinics·2026
Same author

3D endothelial cell scaffolds protect liver explants and exhibit therapeutic effects on liver fibrosis.

JHEP reports : innovation in hepatology·2026
Same author

Nanoengineered Surface-Enhanced Raman Spectroscopy Substrates for Probing Tissue-Material Interactions.

ACS applied materials & interfaces·2026
Same journal

Mitochondrial STING Governs Glycolytic Reprogramming in Diabetic Cardiomyopathy.

Circulation research·2026
Same journal

Hypoxia-Induced Epas1-Myl9/12 Axis Shapes the Pathology of Pulmonary Hypertension.

Circulation research·2026
Same journal

Proteogenomics of Hypertrophic Cardiomyopathy Reveals Subtype-Specific Therapy.

Circulation research·2026
Same journal

Impaired Endothelial Cell Cholesterol Metabolism Promotes Vascular Inflammation in Sleep Apnea.

Circulation research·2026
Same journal

Engineered Heart Tissues Facilitate Noncoding Variant Studies in Cardiomyopathy.

Circulation research·2026
Same journal

NUAK1 Inhibition Alleviates Ischemia-Reperfusion Injury via SYNE1-YAP1.

Circulation research·2026
See all related articles

Tissue engineering offers innovative solutions for cardiovascular diseases, developing biological substitutes to restore heart function. This field shows promise for widespread application in treating conditions like heart failure and vascular issues.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Science

Background:

  • Current treatments for cardiovascular dysfunction, including transplantation and mechanical devices, have limitations and complications.
  • Tissue engineering emerges as an interdisciplinary field applying engineering, material science, and biology to create biological substitutes.
  • Significant progress has been made in engineering cardiovascular components like blood vessels, heart valves, and cardiac muscle.

Purpose of the Study:

  • To review recent advancements in tissue engineering for cardiovascular applications.
  • To highlight pivotal studies supporting the clinical translation of tissue-engineered therapies for cardiovascular diseases.

Main Methods:

  • Endothelial cell seeding of vascular grafts

Related Experiment Videos

  • Development of tissue-engineered vascular conduits
  • Generation of tissue-engineered heart valve leaflets
  • Cardiomyoplasty and genetic manipulation techniques
  • Optimization of in vitro conditions for cardiovascular constructs

    • Main Results:

    • Demonstrated progress in engineering various cardiovascular components.
    • Pivotal studies suggest readiness for widespread application of tissue-engineered therapies.
    • Specific techniques like cell seeding and leaflet generation show promise.

    Conclusions:

    • Tissue engineering provides a promising avenue for addressing cardiovascular diseases.
    • Further research and development in tissue-engineered cardiovascular constructs are crucial.
    • The field is poised to offer improved therapeutic solutions for heart and vascular conditions.